COCP · Cocrystal Pharma, Inc.
$1.09
-0.03 (-2.68%)
At close · Aug 17
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“For the six months ended June 30, 2026, the Company recorded a net loss of approximately $5,463 and used approximately $4,856 of cash in operating activities. These factors raise substantial doubt about the Company's ability to continue as a going concern. In addition, the Company's independent registered public accounting firm, in its report on the Company's December 31, 2025 financial statements, has expressed substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$21.38M
Shares
19.26M
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this stock, matched by the stock's CUSIP. Each row is one fund position with its size, value and weight in that fund.
Funds holding COCP
6 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 187,266 | $189,139 | 0.00% | Long | 2026-03-31 | |
| Fidelity Extended Market Index Fund | — | 49,807 | $55,784 | 0.00% | Long | 2026-05-31 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 52,705 | $53,232 | 0.00% | Long | 2026-03-31 | |
| Fidelity Series Total Market Index Fund | — | 9,629 | $10,784 | 0.00% | Long | 2026-05-31 | |
| Fidelity Total Market Index Fund | — | 8,526 | $9,549 | 0.00% | Long | 2026-05-31 | |
| Fidelity Nasdaq Composite Index Fund | — | 6,122 | $6,857 | 0.00% | Long | 2026-05-31 |
Showing 1–6 of 6 positions
Key facts
CIK
1412486
CUSIP
19188J409
13F (30d)
29 filings
29 filers
Visit website
Investor relations